Novo Nordisk A/S logo
Novo Nordisk A/S NVO
€ 31.56 0.18%

Geschäftsbericht 2025
hinzugefügt 14.03.2026

report update icon

Novo Nordisk A/S Abschreibung & Amortisation 2011-2026 | NVO

Abschreibung & Amortisation Jährlich Novo Nordisk A/S

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - - 6.02 B 5.75 B 5.66 B - - - - - - - -

Alle Zahlen in DKK-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
6.02 B 5.66 B 5.81 B

Abschreibung & Amortisation anderer Aktien in der Pharmaeinzelhändler

Name Abschreibung & Amortisation Preis % 24h Marktkapitalisierung Land
ARCA biopharma ARCA biopharma
ABIO
27 K - 1052.0 % $ 415 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
58 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
100 K - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
744 K - - $ 1.01 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
105 K - 1.93 % $ 17.4 M usaUSA
Akouos Akouos
AKUS
2.49 M - 0.23 % $ 488 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
18 K - - $ 3.67 B usaUSA
I-Mab I-Mab
IMAB
23.9 M - - $ 866 M chinaChina
Amarin Corporation plc Amarin Corporation plc
AMRN
3.02 M $ 14.67 -0.07 % $ 6.09 B irlandaIrlanda
Albireo Pharma Albireo Pharma
ALBO
274 K - -0.23 % $ 916 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
1 K - 10.36 % $ 9.8 M usaUSA
Aptinyx Aptinyx
APTX
122 K - -39.0 % $ 4.57 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
3.87 M - -6.81 % $ 3.04 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.51 M - - $ 26.5 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
162 K - - $ 7.46 M israelIsrael
Atreca Atreca
BCEL
5.46 M - -11.76 % $ 5.79 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
31.7 M - -24.86 % $ 820 K usaUSA
bluebird bio bluebird bio
BLUE
28 M - - $ 546 M usaUSA
Acasti Pharma Acasti Pharma
ACST
7 K - 4.01 % $ 150 M canadaCanada
Cabaletta Bio Cabaletta Bio
CABA
1.65 M $ 2.82 1.44 % $ 283 M usaUSA
Avid Bioservices Avid Bioservices
CDMO
11.1 M - - $ 789 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
3.65 M - - $ 86.2 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
66 K - 2.71 % $ 14 M usaUSA
Advaxis Advaxis
ADXS
369 K - -9.65 % $ 45.9 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
7.55 M $ 1.29 -3.01 % $ 329 M britainBritain
CEL-SCI Corporation CEL-SCI Corporation
CVM
2.14 M $ 3.47 -1.7 % $ 221 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
142 M - 0.49 % $ 251 B cayman-islandsCayman-islands
Denali Therapeutics Denali Therapeutics
DNLI
7.8 M $ 19.74 -12.17 % $ 3.25 B usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
140 K - -4.8 % $ 255 M usaUSA
Cara Therapeutics Cara Therapeutics
CARA
259 K - -3.03 % $ 260 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
3.14 M - - $ 3.74 B usaUSA
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
546 K $ 1.09 -9.17 % $ 22.4 M israelIsrael
Enochian Biosciences Enochian Biosciences
ENOB
129 K - - $ 40.5 M usaUSA
Equillium Equillium
EQ
116 K $ 2.06 - $ 118 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
105 K $ 2.85 3.26 % $ 592 M usaUSA
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
4.04 M $ 23.45 -1.64 % $ 631 M usaUSA
China SXT Pharmaceuticals China SXT Pharmaceuticals
SXTC
82.3 K $ 1.32 -5.2 % $ 1.88 M chinaChina
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
19.5 M $ 47.55 0.98 % $ 4.28 B schweizSchweiz
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
363 K $ 4.45 -1.77 % $ 853 M canadaCanada
Allakos Allakos
ALLK
6.14 M - - $ 28.6 M usaUSA